Rezolute is advancing therapies for serious rare diseases.
Joined September 2012
- Tweets 710
- Following 640
- Followers 603
- Likes 49
348 Photos and videos
Rezoluteโs final poster presentation at #ENDO2026 is coming up!
Davelyn Eaves Hood, MD, MBA, VP of Medical and Patient Affairs, will be presenting ๐๐ถ๐ต๐ค๐ฐ๐ฎ๐ฆ๐ด ๐ช๐ฏ ๐๐ฐ๐ฏ๐จ๐ฆ๐ฏ๐ช๐ต๐ข๐ญ ๐๐บ๐ฑ๐ฆ๐ณ๐ช๐ฏ๐ด๐ถ๐ญ๐ช๐ฏ๐ช๐ด๐ฎ: ๐ ๐๐บ๐ด๐ต๐ฆ๐ฎ๐ข๐ต๐ช๐ค ๐๐ฆ๐ท๐ช๐ฆ๐ธ at 12 PM CDT.
16
What's one thing you wish more people knew about hyperinsulinism?
We're sharing perspectives from our team at #ENDO2026 and highlighting the importance of continued research, awareness, and support for the #hyperinsulinism community.
Learn more: bit.ly/4gqlkMO
36
We kicked off day 2 at #ENDO2026 with a visit to some of our advocacy partners from @congenitalhi.
We're grateful for their shared commitment to improving the lives of individuals and families impacted by #congenitalHI.
#Hyperinsulinism #RareDisease #Rezolute
1
43
Jun 13
We are closing out a great first day at #ENDO2026! Thank you to everyone who stopped by booth #4826 to discuss the latest in #hyperinsulinism.
We're inspired by the conversations weโve had and by the endocrinology community's commitment to advancing #raredisease care.
1
107
Jun 13
Donโt miss our oral presentation and two posters today at #ENDO2026.
Join us to learn more about our work in #hyperinsulinism and connect with our team at booth #4826 afterward for discussion and questions.
ENDO details and agenda: bit.ly/4uo6NEN
#RareDiseaseResearch
1
75
Jun 13
Our team is officially on the ground at #ENDO2026! Weโre excited to connect with healthcare professionals, researchers, and colleagues from across the endocrinology field.
If you're attending, stop by booth #4826 โ we'd love to see you.
Learn more: bit.ly/4uo6NEN
1
3
76
Jun 12
Weโre looking forward to kicking off #ENDO2026 soon!
Tomorrow, we start strong with one oral presentation and two posters. Be sure to join, and stop by booth #4826 afterward to continue the conversation with our team.
View our presentation details here: bit.ly/4uSZ1Eb
1
62
Jun 12
This weekend, weโll cheer on the @congenitalhi CHIbra team during the Million Dollar Bike Ride. Team CHIbra will be riding to accelerate progress toward better diagnostics, improved treatments, and a cure for #hyperinsulinism.
See how you can support: bit.ly/4vJ2QvB
13
Jun 10
Today at the @OrphanConf in Boston, Rezolute's founder and CEO Nevan Charles Elam will join #biotech leaders for a panel discussion about the unique challenges facing #raredisease drug developers. We hope to see you at 3:10 PM EDT!
Learn more: bit.ly/4ghVn1U
#WODCUSA
23
Jun 8
To celebrate this yearโs #GlobalHIAwarenessDay, our team came together to reflect on our "7 Things for June 7" and how the #hyperinsulinism community inspires us.
Together, we can shape a better future of #raredisease care.
#WhatstheBuzz #CongenitalHI #Rezolute
1
1
32
Jun 7
As the sun rises on #GlobalHIAwarenessDay, weโre joining patient advocacy groups around the world and the many #hyperinsulinism families they touch in sharing our โ7 Things for June 7โ โ 7 thoughts about how the congenital HI community inspires us every day.
#CongenitalHI
1
1
29
Jun 5
We're heading to New Orleans for the Neuroendocrine Cancer Awareness Network's NET Patient Conference! This is a great opportunity to learn from leading experts, explore the latest in NET care, and connect with an incredible community.
Learn more: bit.ly/4uUshug
23
Jun 5
Global HI Awareness Day is this Sunday, June 7!
On this day, we celebrate the incredible advocacy organizations around the worldโincluding @congenitalhi, @CHCharityUK, Kongenitaler Hyperinsulinismus e.V., @hicongenito, and others. Your partnership and perseverance are inspiring.
1
1
59
Jun 4
Weโre pleased to announce four presentations at the Annual Meeting of the Endocrine Society (ENDO) being held in Chicago, IL later this month, including one oral and three poster presentations.
Full presentation details: bit.ly/4uSZ1Eb
#ENDO2026 #CongenitalHI #TumorHI
1
43
Jun 3
This week, we'll be at the @Jefferies Global Healthcare Conference, where our leadership team will discuss the transformative potential of ersodetug for patients with #hyperinsulinism.
Watch our fireside chat on Thursday, June 4 at 3:45 PM EDT here: bit.ly/43QgYqM
46
Jun 2
Today we announced positive interim data from our Phase 3 upLIFT study of ersodetug in tumor hyperinsulinism. The study is now 50% enrolled, and 6 of 8 participants have already met the responder criterion for the studyโs primary endpoint.
Learn more: bit.ly/43dUlfQ
55
Jun 1
"Together for Parents" โ this year's #GlobalDayOfParents theme โ reminds us that no family should face #raredisease alone.
Thank you @UNICEF for highlighting the realities of caregiving. Learn more about the Global Day of Parents: bit.ly/4wYOmZW
#Hyperinsulinism
26
May 29
Stories from families living with #hyperinsulinism drive us forward.
Weโre working toward creating a different world - one where patients and caregivers no longer live in fear of unpredictable hypoglycemic lows.
Learn more: bit.ly/3OmZq0Z
#Rezolute #CongenitalHI
1
1
41
May 20
Today we celebrate #ClinicalTrialsDay and honor the families and professionals driving critical research forward.
Thank you to the study participants, research professionals, and clinicians advancing medicine.
Learn more about our clinical trials here: bit.ly/42LzGj6
31
May 18
We're excited to participate in the @HCWCO #BioConnect Investor Conference in New York this week.
If youโre attending, we look forward to connecting to share updates on the exciting milestones ahead for our two late-stage #hyperinsulinism programs.
#congenitalHI #tumorHI
1
32